Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antigoni Lekka

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cancer Causes & Control : CCC|December 8, 2007
Is thyroid autoimmunity a risk factor for developing primary myelodysplastic syndrome?Maria Dalamaga, Antigoni Lekka, Konstantinos Karmaniolas, et al.
Menopause (New York, N.Y.)|March 14, 2013
Hyperresistinemia is associated with postmenopausal breast cancerMaria Dalamaga, Konstantinos Karmaniolas, Evangelia Papadavid, et al.
Menopause (New York, N.Y.)|June 30, 2011
Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parametersMaria Dalamaga, Konstantinos Karmaniolas, Evangelia Papadavid, et al.
Clinical Biochemistry|January 17, 2013
Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parametersMaria Dalamaga, George Sotiropoulos, Konstantinos Karmaniolas, et al.
Maturitas|January 21, 2012
Could serum visfatin be a potential biomarker for postmenopausal breast cancer?Maria Dalamaga, Stavros Archondakis, George Sotiropoulos, et al.
Metabolism: Clinical and Experimental|October 22, 2013
Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndromeMaria Dalamaga, Konstantinos Karmaniolas, John Chamberland, et al.
Cancer Causes & Control : CCC|September 25, 2008
Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control studyMaria Dalamaga, Konstantinos Karmaniolas, Anna Panagiotou, et al.
Disease Markers|September 10, 2010
Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet countMaria Dalamaga, Konstantinos Karmaniolas, Antigoni Lekka, et al.
Leukemia & Lymphoma|August 29, 2015
Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control studyMaria Dalamaga, Stergios A Polyzos, Konstantinos Karmaniolas, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 28, 2014
Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control studyMaria Dalamaga, Stergios A Polyzos, Konstantinos Karmaniolas, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancer Causes & Control : CCC|December 8, 2007
Is thyroid autoimmunity a risk factor for developing primary myelodysplastic syndrome?Maria Dalamaga, Antigoni Lekka, Konstantinos Karmaniolas, et al.
Menopause (New York, N.Y.)|March 14, 2013
Hyperresistinemia is associated with postmenopausal breast cancerMaria Dalamaga, Konstantinos Karmaniolas, Evangelia Papadavid, et al.
Menopause (New York, N.Y.)|June 30, 2011
Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parametersMaria Dalamaga, Konstantinos Karmaniolas, Evangelia Papadavid, et al.
Clinical Biochemistry|January 17, 2013
Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parametersMaria Dalamaga, George Sotiropoulos, Konstantinos Karmaniolas, et al.
Maturitas|January 21, 2012
Could serum visfatin be a potential biomarker for postmenopausal breast cancer?Maria Dalamaga, Stavros Archondakis, George Sotiropoulos, et al.
Metabolism: Clinical and Experimental|October 22, 2013
Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndromeMaria Dalamaga, Konstantinos Karmaniolas, John Chamberland, et al.
Cancer Causes & Control : CCC|September 25, 2008
Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control studyMaria Dalamaga, Konstantinos Karmaniolas, Anna Panagiotou, et al.
Disease Markers|September 10, 2010
Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet countMaria Dalamaga, Konstantinos Karmaniolas, Antigoni Lekka, et al.
Leukemia & Lymphoma|August 29, 2015
Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control studyMaria Dalamaga, Stergios A Polyzos, Konstantinos Karmaniolas, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 28, 2014
Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control studyMaria Dalamaga, Stergios A Polyzos, Konstantinos Karmaniolas, et al.
Pageof 2